What's Going On With Ampio Pharmaceuticals Stock?
Portfolio Pulse from Erica Kollmann
Ampio Pharmaceuticals, Inc. (AMEX:AMPE) shares dropped significantly on Friday after a more than 200% spike on Thursday. The trading volume was more than double the 100-day average, with over 738 thousand shares traded. The company, which is developing treatments for severe Osteoarthritis of the Knee and COVID-19, has a small float of less than 815 thousand shares. The stock price fell by 44% to $3.20.
December 01, 2023 | 6:46 pm
News sentiment analysis
Sort by:
Descending
NEGATIVE IMPACT
Ampio Pharmaceuticals' stock plummeted after a significant surge, with trading volume exceeding the average and a small float contributing to volatility.
The sharp increase in trading volume and the subsequent price drop suggest a potential sell-off following the previous day's spike. Given the small float, the stock is likely to be more volatile, which could lead to further short-term price declines.
CONFIDENCE 85
IMPORTANCE 90
RELEVANCE 100